A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria

Parasite Immunology

Volumn 30, Issue 3, 2008, Pages 133-138

  De Mast, Q ^a   Sweep, F C G J ^a   McCall, M ^a   Geurts Moespot, A ^a   Hermsen, C ^a   Calandra, T ^b   Netea, M G ^a   Sauerwein, R W ^a   Van Der Ven, A J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Lymphocytes; Lymphocytopenia; Macrophage migration inhibitory factor; Malaria; MIF; Plasmodium falciparum

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFECTION COMPLICATION; LYMPHOCYTE; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANIMALS; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-8; LYMPHOCYTE COUNT; LYMPHOCYTES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MALARIA, FALCIPARUM; MALE; MONOCYTES; PLASMODIUM FALCIPARUM; TIME FACTORS;

PLASMODIUM FALCIPARUM;

EID: 38649087030     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2007.01008.x     Document Type: Article

References (29)

1. World malaria situation in 1994. Part I. Population at risk. Wkly Epidemiol Rec 1997 72 : 269 274.
2. Clark IA, Budd AC, Alleva LM Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar J 2006 5 : 85.
3. Calandra T Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003 3 : 791 800.
4. Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995 377 : 68 71.
5. Satoskar AR, Bozza M, Rodriguez SM, Lin G David JR. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun 2001 69 : 906 911.
6. Stavitsky AB, Metz C, Liu S, Xianli J Bucala R. Blockade of macrophage migration inhibitory factor (MIF) in Schistosoma japonicum-infected mice results in an increased adult worm burden and reduced fecundity. Parasite Immunol 2003 25 : 369 374.
7. McDevitt MA, Xie J, Shanmugasundaram G, et al. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J Exp Med 2006 203 : 1185 1196.
8. Awandare GA, Hittner JB, Kremsner PG, et al. Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. Clin Immunol 2006 119 : 219 225.
9. Awandare GA, Ouma Y, Ouma C, et al. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun 2007 75 : 201 210.
10. Verhage DF, Telgt DS, Bousema JT, et al. Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med 2005 63 : 52 58.
11. Schneider P, Wolters L, Schoone G, et al. Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum. J Clin Microbiol 2005 43 : 402 405.
12. Radstake TR, Sweep FC, Welsing P, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005 52 : 3020 3029.
13. Drenth JP, Van Uum SH, Van DM, Pesman GJ, Vand V Van der Meer JW. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 1995 79 : 1497 1503.
14. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996 93 : 7849 7854.
15. Hermsen CC, Konijnenberg Y, Mulder L, et al. Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections. Clin Exp Immunol 2003 132 : 467 472.
16. Wu J, Cunha FQ, Liew FY Weiser WY. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J Immunol 1993 151 : 4325 4332.
17. Lisse IM, Aaby P, Whittle H Knudsen K. A community study of T lymphocyte subsets and malaria parasitaemia. Trans R Soc Trop Med Hyg 1994 88 : 709 710.
18. Wells RA, Pavanand K, Zolyomi S, Permpanich B MacDermott RP. Loss of circulating T lymphocytes with normal levels of B and 'null' lymphocytes in Thai adults with malaria. Clin Exp Immunol 1979 35 : 202 209.
19. Elhassan IM, Hviid L, Satti G, et al. Evidence of endothelial inflammation, T cell activation, and T cell reallocation in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 1994 51 : 372 379.
20. Hviid L Kemp K. What is the cause of lymphopenia in malaria? Infect Immun 2000 68 : 6087 6089.
21. Kumararatne DS, Phillips RS, Sinclair D, Parrott MV Forrester JB. Lymphocyte migration in murine malaria during the primary patent parasitaemia of Plasmodium chabaudi infections. Clin Exp Immunol 1987 68 : 65 77.
22. Kern P, Dietrich M, Hemmer C Wellinghausen N. Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria. Infect Immun 2000 68 : 3061 3063.
23. Matsumoto J, Kawai S, Terao K, et al. Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection. Infect Immun 2000 68 : 1183 1188.
24. Isidori AM, Kaltsas GA, Korbonits M, et al. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. J Clin Endocrinol Metab 2002 87 : 1834 1840.
25. Chaisavaneeyakorn S, Moore JM, Othoro C, et al. Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. J Infect Dis 2002 186 : 1371 1375.
26. Chaiyaroj SC, Rutta AS, Muenthaisong K, Watkins P, Na UM Looareesuwan S. Reduced levels of transforming growth factor-β1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. Acta Trop 2004 89 : 319 327.
27. Awandare GA, Ouma C, Keller CC, et al. A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria. Genes Immun 2006 7 : 568 575.
28. Awandare GA, Kremsner PG, Hittner JB, et al. Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria. Am J Trop Med Hyg 2007 76 : 1033 1036.
29. Mizue Y, Nishihira J, Miyazaki T, et al. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 2000 5 : 397 403.